DS
Douglas J Swirsky
Chief Financial Officer

Douglas J Swirsky insider trades: Maxcyte (MXCT) stock buys and sales

Chief Financial Officer, Maxcyte Last trade Mar 17, 2026 58 Form 4 filings
$8K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2007
8
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Douglas reports to the SEC

and 2 more companies

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 17, 2026MXCT↓ Sell$8K
Aug 13, 2025MXCT↑ Buy$65K
Mar 18, 2025MXCT↓ Sell$22K
Sep 14, 2021CLRB↑ Buy$26K
Jan 29, 2019RNN↑ Buy$32K
Sep 16, 2016GNVC↑ Buy$5K
Dec 14, 2015GNVC↑ Buy$10K
Aug 12, 2011GNVC↑ Buy$56K
Aug 12, 2011GNVC↑ Buy$2K
Nov 19, 2008GNVC↑ Buy$7K
Nov 15, 2007GNVC↑ Buy$12K
Mar 19, 2007GNVC↑ Buy$13K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Douglas J Swirsky's insider trades

Douglas J Swirsky is Chief Financial Officer at Maxcyte (MXCT). Since Mar 19, 2007, Douglas has reported 10 open-market purchases worth $226K and 2 sales worth $30K on SEC Form 4. In the last 12 months: 1 sale ($8K).

Their filings also include grants and awards (45 filings), shares returned to the company (2 filings), option exercises (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MXCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.